Barclays Reaffirms Their Buy Rating on Corteva (CTVA)
In a report released yesterday, Benjamin Theurer from Barclays maintained a Buy rating on Corteva, with a price target of $84.00. The company’s shares closed yesterday at $65.09.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
According to TipRanks, Theurer is a 3-star analyst with an average return of 3.0% and a 48.11% success rate. Theurer covers the Consumer Defensive sector, focusing on stocks such as Hormel Foods, Coca Cola Femsa SAB De CV, and Tyson Foods.
Corteva has an analyst consensus of Strong Buy, with a price target consensus of $78.31, implying a 20.31% upside from current levels. In a report released on December 4, Jefferies also maintained a Buy rating on the stock with a $85.00 price target.
Based on Corteva’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $2.62 billion and a GAAP net loss of $320 million. In comparison, last year the company earned a revenue of $2.33 billion and had a GAAP net loss of $524 million
Read More on CTVA:
Disclaimer & DisclosureReport an Issue
- Corteva’s Growth Potential Bolstered by Strategic Collaborations and Legal Developments
- Corteva assumed with an Overweight at Wells Fargo
- Corteva price target raised to $76 from $75 at Oppenheimer
- Corteva’s Strategic Adjustments and Strong Crop Protection Performance Drive Buy Rating
- Corteva’s Strong Q3 Performance Boosts 2025 Outlook
